Pharmacokinetics and Pharmacodynamics of 9‐cis‐Retinoic Acid in Healthy Men (Q73556891)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9243349 AND SRC:MED&resulttype=core&format=json

5 November 2019

title

Pharmacokinetics and pharmacodynamics of 9-cis-retinoic acid in healthy men (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9243349 AND SRC:MED&resulttype=core&format=json

5 November 2019

Pharmacokinetics and Pharmacodynamics of 9‐cis‐Retinoic Acid in Healthy Men (English)

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1997.TB04338.X

9 November 2024

1 reference

1 reference

C. Weber

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9243349

9 November 2024

E. Dumont

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9243349

9 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9243349

9 November 2024

publication date

1 July 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9243349 AND SRC:MED&resulttype=core&format=json

5 November 2019

July 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9243349

full work available at URL

9 November 2024

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002/j.1552-4604.1997.tb04338.x

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1997.TB04338.X

https://accp1.onlinelibrary.wiley.com/doi/pdf/10.1002/j.1552-4604.1997.tb04338.x

9 November 2024

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1997.TB04338.X

The Journal of Clinical Pharmacology

9 November 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9243349 AND SRC:MED&resulttype=core&format=json

5 November 2019

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9243349 AND SRC:MED&resulttype=core&format=json

5 November 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9243349 AND SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

566-574

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9243349 AND SRC:MED&resulttype=core&format=json

Retinoids in cancer therapy

5 November 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1997.TB04338.X

9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα

9 November 2024

5

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1997.TB04338.X

9-cis retinoic acid is a high affinity ligand for the retinoid X receptor

9 November 2024

6

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1997.TB04338.X

Characterization of three RXR genes that mediate the action of 9-cis retinoic acid

9 November 2024

7

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1997.TB04338.X

Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids

9 November 2024

8

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1997.TB04338.X

Differentiation-inducing activity of retinoic acid isomers and their oxidized analogs on human promyelocytic leukemia HL-60 cells

9 November 2024

10

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1997.TB04338.X

Mechanism of synergistic action of all-trans- or 9-cis-retinoic acid and interferons in breast cancer cells

9 November 2024

12

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1997.TB04338.X

Phase I and pharmacokinetic evaluation of all-trans-retinoic acid in pediatric patients with cancer

9 November 2024

18

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1997.TB04338.X

Quantitative relationships between toxic doses of antitumor chemotherapeutic agents in animals and man

9 November 2024

20

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1997.TB04338.X

Choice of starting dose and escalation for phase I studies of antitumor agents

9 November 2024

21

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1997.TB04338.X

Clinical pharmacokinetics of the retinoids

9 November 2024

25

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1997.TB04338.X

The pharmacology and pharmacokinetics of the retinoids

9 November 2024

26

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1997.TB04338.X

Retinoids: in vitro interaction with retinol-binding protein and influence on plasma retinol

9 November 2024

27

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1997.TB04338.X

Five-year administration of fenretinide: pharmacokinetics and effects on plasma retinol concentrations

9 November 2024

29

1 reference

https://api.crossref.org/works/10.1002/J.1552-4604.1997.TB04338.X

9 November 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9243349 AND SRC:MED&resulttype=core&format=json

5 November 2019

1 reference